Search Results - "Khodabakhshian, Aleen"

Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation by Gandhi, Malini M, Nguyen, Kim-Lien, Lake, Jordan E, Liao, Diana, Khodabakhshian, Aleen, Guerrero, Mario, Shufelt, Chrisandra L, Bairey Merz, C Noel, Jordan, Wilbert C, Daar, Eric S, Bhattacharya, Debika, Chew, Kara W

“…Proprotein convertase subtisilin/kexin 9 (PCSK9) raises low-density lipoprotein cholesterol (LDL-C) levels and is associated with inflammation, which is…”
Get full text

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention by Hoffmann, Udo, Lu, Michael T, Foldyna, Borek, Zanni, Markella V, Karady, Julia, Taron, Jana, Zhai, Bingxue K, Burdo, Tricia, Fitch, Kathleen V, Kileel, Emma M, Williams, Kenneth, Fichtenbaum, Carl J, Overton, Edgar T, Malvestutto, Carlos, Aberg, Judith, Currier, Judith, Sponseller, Craig A, Melbourne, Kathleen, Floris-Moore, Michelle, Van Dam, Cornelius, Keefer, Michael C, Koletar, Susan L, Douglas, Pamela S, Ribaudo, Heather, Mayrhofer, Thomas, Grinspoon, Steven K

“…Cardiovascular disease (CVD) is increased among people with HIV (PWH), but little is known regarding the prevalence and extent of coronary artery disease (CAD)…”
Get full text

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial by Ritz, Justin, Li, Jonathan Z., Wohl, David, Giganti, Mark, Patel, Nilam, Colsh, Kelly, Evering, Teresa H., Ignacio, Rachel Bender, Jilg, Nikolaus, Perelson, Alan, Taiwo, Babafemi, Gottesman, Joan, Newell, Matthew, Pedersen, Susan, Gapara, Morgan, Margolis, David, Nuñez, Sebastian, Papasidero, Marcelo, Wehbe, Luis, Voena, Felicitas Fernandez, Lopez, Amaru, Huhn, Virginia, Dieser, Pablo, Mussi, Marisa, de Carvalho Santana, Rodrigo, Tiraboschi Bárbaro, Adriana Aparecida, Santos, Breno, Cardoso, Sandra Wagner, Diniz Ribeiro, Maria Pia, Vasconcellos, Eduardo, Faleiro Ferreira, Flávia Gomes, Bohorquez Lopez, Victor Casildo, Coetzer, Thomas, Madlala, Penelope, Petrick, Frederick, Mbali, Rose, Zwane, Zinhle, Chiperera, Tendai, Mohapi, Lerato, Singh, Usha, McHarry, Kirsten, Snyman, Elizma, Adonis, Tania, Sein, Ni Ni, Mitha, Ismail, Lummus, Christie, Kim, Andrew, Kao, Wei-Hsin, Pfeffer, Michael M., Arnold, Melanie, Karpf, Cinzia, Yawetz, Sigal, Keenan, Cheryl, Milstone, Aaron, Berardi, Jonathan, Arar, Celine, Gomez-Martinez, Marissa, Focil, Augusto, Rosas, Griselda, Bukhman, Eugene, Farah, Humam, Kingsley, Jeffrey, Herman, Craig, Leon, Ramon, Nikolov, Boris, Jagizarov, Zarema, Becker, Becky, Maldonado, Valarie, Veltman, Jennifer, Pullman, John, Johnson, Misty, Hecker, Michelle, Wernick, Arthur, Ruiz, Karelia, Harber, Heather, Cicarella, Robyn, Pulliam, Sallie D., Socorro, Estefania, Neytman, Gene, Aziz, Mariam, Swiatek, Joan, Hoover, Susan E., Weston, Patrick, Sullivano, Jennifer, Clemency, Brian, Khodabakhshian, Aleen, Fortier, Samantha, Rathore, Mobeen, Mahmoudi, Saniyyah, Spikes, Leslie, Hall, Chase, Loftis, Amy James, Short, William, Mendez, Luis M., Jonsson, Chris, Nakatani, Lisa, Williamson, Derrick, Atriss, Hisham, Caloura, Matthew, Presti, Rachel

“…It is unknown if early COVID-19 monoclonal antibody (mAb) therapy can reduce risk of Long COVID. The mAbs amubarvimab/romlusevimab were previously demonstrated…”
Get full text

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial by Jagannathan, Prasanna, Giganti, Mark J., Hughes, Michael D., Moser, Carlee, Main, Mark J., Monk, Phillip D., Javan, Arzhang Cyrus, Fletcher, Courtney V., McCarthy, Caitlyn, Wohl, David A., Daar, Eric S., Eron, Joseph J., Singh, Upinder, Smith, Davey M., Fischer, William, Chew, Kara, Smith, David (Davey), Daar, Eric, Wohl, David, Currier, Judith, Eron, Joseph, Javan, Arzhang Cyrus, Moser, Carlee, Giganti, Mark, Hosey, Lara, Roa, Jhoanna, Patel, Nilam, Colsh, Kelly, Rwakazina, Irene, Sieg, Scott, Li, Jonathan, Fletcher, Courtney, Fischer, William, Evering, Teresa, Ignacio, Rachel Bender, Cardoso, Sandra, Corado, Katya, Jagannathan, Prasanna, Jilg, Nikolaus, Perelson, Alan, Pillay, Sandy, Riviere, Cynthia, Singh, Upinder, Taiwo, Babafemi, Gottesman, Joan, Newell, Matthew, Pedersen, Susan, Dragavon, Joan, Jennings, Cheryl, Greenfelder, Brian, Murtaugh, William, Gapara, Morgan, Shahkolahi, Akbar, Main, Mark J., Pierone, Gerald, Elliott, Juliana, Jacobson, Jeffrey, Hojat, Leila, Pasternak, Julie, Berardi, Jonathan, Arar, Celine, Bukhman, Yevgeniy, Jain, Manish, Bukhman, Eugene, Shaik, Sadia, Hatlen, Timothy, Dooley, Kelly, Wilkins, Adaliah, Pérez, Jose, Fernández, Heriberto, Hoover, Keila, Renfroe, James, Weldon, Mauney, Bougher, Genei, Malvestutto, Carlos, Harber, Heather, Cicarella, Robyn, Neytman, Gene, Herman, Jack, Herman, Craig, Swiatek, Joan, Pathak, Divya, Choudhary, Madhu, Sullivano, Jennifer, Torna, Odelsey, Khodabakhshian, Aleen, Benson, Constance, Hendrickx, Steven, Luetkemeyer, Anne, Dentoni-Lasofsky, Dennis, Spikes, Leslie, Hall, Chase, Oakes, Jonathan, Loftis, Amy James, Tebas, Pablo, Short, William, McGuffin, Sarah, Jonsson, Chris, Presti, Rachel, Haile, Alem

“…With the emergence of SARS-CoV-2 variants resistant to monoclonal antibody therapies and limited global access to therapeutics, the evaluation of novel…”
Get full text

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context by Prasanna Jagannathan, Kara W. Chew, Mark J. Giganti, Michael D. Hughes, Carlee Moser, Mark J. Main, Phillip D. Monk, Arzhang Cyrus Javan, Jonathan Z. Li, Courtney V. Fletcher, Caitlyn McCarthy, David A. Wohl, Eric S. Daar, Joseph J. Eron, Judith S. Currier, Upinder Singh, Davey M. Smith, William Fischer, Kara Chew, David (Davey) Smith, Eric Daar, David Wohl, Judith Currier, Joseph Eron, Arzhang Cyrus Javan, Michael Hughes, Carlee Moser, Mark Giganti, Justin Ritz, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, Jonathan Li, Courtney Fletcher, William Fischer, Teresa Evering, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Alan Perelson, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Mark J. Main, Gerald Pierone, Juliana Elliott, Jeffrey Jacobson, Leila Hojat, Julie Pasternak, Jonathan Berardi, Celine Arar, Yevgeniy Bukhman, Manish Jain, Eugene Bukhman, Sadia Shaik, Timothy Hatlen, Kelly Dooley, Becky Becker, Adaliah Wilkins, Jose Pérez, Eloy Roman, Heriberto Fernández, Keila Hoover, James Renfroe, Mauney Weldon, Genei Bougher, Carlos Malvestutto, Heather Harber, Robyn Cicarella, Gene Neytman, Jack Herman, Craig Herman, Mariam Aziz, Joan Swiatek, Divya Pathak, Madhu Choudhary, Jennifer Sullivano, Olayemi Osiyemi, Myriam Izquierdo, Odelsey Torna, Aleen Khodabakhshian, Samantha Fortier, Constance Benson

“…Background: With the emergence of SARS-CoV-2 variants resistant to monoclonal antibody therapies and limited global access to therapeutics, the evaluation of…”
Get full text